Corneas with edema-related diseases lose transparency, which causes significant vision loss. This study analyzed seven aquaporins (AQPs) in normal corneas, pseudophakic/aphakic bullous keratopathy (PBK/ABK) corneas, Fuchs' dystrophy corneas, keratoconus corneas, post-cataract surgery (PCS) corneas, and normal organ-cultured corneas. RNA levels for AQP1, AQP4, and ␤ 2 -microglobulin were measured by RT-PCR. AQP1 antibody localized to stromal cells of all corneas. PBK/ABK and Fuchs' dystrophy corneas had decreased endothelial cell staining compared with normal. AQP1 mRNA was found in whole corneas and cultured stromal fibroblasts but not in isolated epithelial cells. AQP3 staining was found in basal epithelial cells of the normal, Fuchs' dystrophy, and keratoconus corneas but throughout the entire epithelium of PBK/ABK corneas. AQP4 antibody localized to endothelial cells of all corneas and in stromal cells of PBK/ABK corneas. AQP4 mRNA was identified in whole human corneas. AQP5 was found in epithelial cells of all corneas. AQP0, AQP2, and AQP9 were not found in any corneas. Normal AQP distributions were found in PCS and organ-cultured corneas, although they showed signs of swelling. Our study demonstrates that AQP abnormalities are found in PBK/ABK corneas (decreased AQP1, increased AQP3 and AQP4) and Fuchs' dystrophy corneas (decreased AQP1). Although both have vision-disrupting corneal edema, the mechanisms of fluid accumulation may be different in each disease. (J Histochem Cytochem 52: [1341][1342][1343][1344][1345][1346][1347][1348][1349][1350] 2004) 
Aquaporins (AQPs) are recently discovered water channel proteins found in animals, plants and microorganisms. These molecular channels are essential for the regulation of water in all living cells and tissues (Kang et al. 2000; King et al. 2000; Verkman 2002) , and excellent review articles on AQPs are available (Kang et al. 2000; King et al. 2000; Agre et al. 2002; Verkman 2002 Verkman ,2003 .
Most of the information regarding AQP molecular structure was obtained on AQP1, a 28-kD monomer with six transmembrane domains and intracellular N-and C-termini (King et al. 2000) . A common motif defined by Asn-Pro-Ala (NPA) is found in all AQPs. These motif regions fold together to form the aqueous pore in the cell membrane. AQP0 has low water permeability, whereas AQP3, AQP7, AQP9, and AQP10 transport both water and small non-ionic solutes such as urea and glycerol (King et al. 2000) . The other aquaporins, AQP1, AQP2, AQP4, AQP5, and AQP8, transport only water and exclude small solutes. AQP6 is found in membranes of kidney intracellular vesicles and may function as a nitrate channel rather than a water channel (Ikeda et al. 2002) . The presence of the cysteine 189 residue in most AQPs confers mercury sensitivity, with the exception being AQP4, which is mercury-insensitive (Han et al. 1998 ).
More than 10 AQPs have been reported (King et al. 2000; Agre and Kozono 2003; Verkman 2003) , and at least five are found in the eye. AQP0 (major intrinsic protein, MIP) is a major protein of the vertebrate lens cell membranes (Nemeth-Cahalan and Hall 2000; Zampighi et al. 2002) . Cataracts occur in the AQP0deficient mouse model, which harbors mutations in AQP0 (Berry et al. 2000) . AQP1 is reported in the non-pigmented ciliary body, iris, scleral fibroblasts, anterior lens epithelium, corneal endothelium, corneal stromal cells, trabecular meshwork, Schlemm's canal endothelium, and retina (Hamann et al. 1998; Kim et al. 1998 Kim et al. ,2002 Kang et al. 1999; Verkman 2003; Macnamara et al. 2004) . AQP3 is found in the bulbar conjunctival epithelium and the cornea (Patil et al. 1997; Hamann et al. 1998) . AQP4 is in the ciliary body, iris, conjunctival epithelium, retinal Müller cells, and astrocytes (Hasegawa et al. 1994; Nagelhus et al. 1999) . AQP5 is reported in lacrimal gland, cornea, and cultured epithelial cells (Raina et al. 1995; Patil et al. 1997; Kang et al. 1999) . Lower AQP1 expression was reported in corneas with endothelial cell dysfunction (Macnamara et al. 2004 ), but a comprehensive evaluation of other AQPs in human diseased corneas has not been performed.
The goal of the present study was to characterize the AQPs found in PBK/ABK corneas and Fuchs' endothelial dystrophy corneas, both diseases characterized by chronic corneal edema. To verify that any changes of AQPs were specific to PBK/ABK corneas or Fuchs' dystrophy corneas, we also examined corneas with other pathologies. Keratoconus is a corneal disease that is characterized by disruptions in Bowman's layer, progressive steepening of the cornea, excessive stromal thinning, and no known association with abnormal fluid dynamics. Another category of corneas examined were post-cataract surgery (PCS) normal corneas, because previous studies showed that these corneas had specific changes in their epithelial basement membranes similar to those observed in PBK/ABK and Fuchs' dystrophy corneas (Ljubimov et al. 2002) .
Finally, we wanted to determine if a corneal organ culture model reflected the AQP patterns found in normal in situ corneas. Fortunately, a model was described that allows extended culture of intact whole human corneas (Foreman et al. 1996; Harper et al. 1998 ). These corneas can be transplanted successfully even after 1 month in culture (Harper et al. 1998) . Corneal organ cultures were established and the AQP patterns analyzed.
We found that PBK/ABK corneas had the most alterations in the AQPs, with abnormal staining for AQP1, AQP3, and AQP4. Fuchs' dystrophy corneas, another disease with chronic edema, had changes in AQP1. Otherwise, keratoconus corneas, organ-cultured normal corneas, and PCS corneas had essentially normal AQP staining patterns.
Materials and Methods
Immunohistochemistry Healthy (normal) and PCS autopsy corneas were collected from National Disease Research Interchange (NDRI; Philadelphia, PA) within 24 hr after enucleation. The PCS corneas were from eyes that had undergone cataract surgery and had an artificial intraocular lens in place. The diseased corneas were received from various surgeons within 24 hr of the corneal transplant surgery. Tissues were sent to our laboratory on ice, were rinsed thoroughly in cold PBS, pH 7.2, and embedded in Tissue Tek OCT compound. The blocks were frozen rapidly in liquid nitrogen and 5-m sections cut on a Leica cryostat. The sections were treated with Ultra V Block (Neomarkers; Fremont, CA) for 15 min and antibodies were diluted in Diluent (Neomarkers). Total numbers of corneas studied were as follows: normal ( n ϭ 13), bullous keratopathy ( n ϭ 15), Fuchs' dystrophy ( n ϭ 12), keratoconus ( n ϭ 11), PCS corneas ( n ϭ 11), and organ-cultured corneas ( n ϭ 5).
Polyclonal antibodies were used to the following: AQP0 (8 g/ml, cat #AQP01-A, lot #3232A; Alpha Diagnostic International, Austin, TX); AQP1 (5 g/ml, cat #AB3272-50UL, lot #21040737, residues 243-261; Chemicon International, Temecula, CA); AQP2 (8 g/ml, cat. #AB3066, lot #21042068; Chemicon); AQP3 (7 g/ml, A0303, residues 275-292 with additional N-terminal lysine and tyrosine; Sigma Chemical, St Louis, MO); AQP4 (2 g/ml, cat. #AB 3594-50UL, lot # 21040738, residues 249-323; Chemicon); AQP5 (4 g/ml, G-19:sc-9890; Santa Cruz Biotechnology, Santa Cruz, CA); AQP5 (10 g/ml, polyclonal, AB3069; synthetic peptide (aa 249-265); Chemicon); AQP5 (10 g/ ml, cat. #178615, cytoplasmic 17-amino-acid peptide near the C-terminus with an additional cysteine residue added; Calbiochem-Novabiochem, San Diego, CA); and AQP9 (8 g/ml, affinity-purified, cat. #AQP91-A, lot #3232A; Alpha Diagnostic International). Rhodamine-conjugated goat antirabbit IgG or donkey anti-goat IgG (25 g/ml; Chemicon) was used as the secondary antibody. As a control for AQP5, we purchased the peptides to which the antibodies were made (Santa Cruz Biotechnology and Chemicon). The primary antibody was neutralized overnight at 4C before staining. Another control was the use of secondary antibodies only. Sections were viewed and photographed using an Olympus BH-2 microscope (Olympus USA; Melville, NY) equipped with epifluorescence.
Corneal Organ Cultures
Some corneas were placed in a long-term organ culture system to determine whether conditions could be established in vitro that allowed the human corneas to maintain their AQP patterns. The technique allows extended culture of intact whole human corneas (Foreman et al. 1996; Harper et al. 1998; Xu et al. 2000; Zieske 2000) . Postmortem human corneas with the scleral rims were obtained from NDRI within 24 hr after death. Corneas were organ-cultured over agarcollagen gel as described (Kabosova et al. 2003) . They were first washed in antibiotic-antimycotic mixture (ABAM; Invitrogen) and then placed epithelial side down in sterile Chiron's corneal transportation vials with a small volume of medium to prevent drying. The corneal concavity was filled with serum-free minimal essential medium (MEM; Invitrogen) containing ABAM, 1 mg/ml calf skin collagen (made from stock solution of 10 mg/ml in 0.1 N acetic acid), and 1% agar (both from Sigma Chemical). This mixture was microwaved until boiling to sterilize it and to dissolve the agar and then was cooled to 37-39C. After the addition to corneas, the mixture solidified within 2-3 min. Corneas were then placed agar side down on a sterile 60-mm dish. Serumfree MEM containing ABAM and insulin-transferrin-sodium selenite (ITS supplement; Sigma) was then added dropwise to the central cornea until it reached the limbus. Corneas were kept in a humidified CO 2 incubator at 35.5C and 100 l medium was added one or two times a day to moisten the epithelium. Corneal morphology and cell viability were monitored microscopically with a ϫ 4 objective. After 10-14 days in culture, the corneas were harvested, embedded in OCT medium, and rapidly frozen in liquid nitrogen. The tissues were sectioned and stained with AQP antibodies.
Tissue Culture of Corneal Fibroblasts
Fibroblasts were cultured from normal corneas ( n ϭ 4) and a PBK cornea ( n ϭ 1) to determine if AQP1, which is highly expressed in the intact whole cornea stromal cells, was also expressed in vitro. The normal corneas were received within 24 hr after death from the NDRI. The PBK cornea was received within 24 hr after surgery. After removal of the corneal epithelial and endothelial layers, primary stromal cell cultures were established (Kenney et al. 1994 (Kenney et al. ,2003 . Duplicate third-passage cultures were grown to confluence in MEM supplemented with 10% fetal bovine serum. Normal and PBK fibroblasts were plated into 60-mm dishes at 5 ϫ 10 5 cells/plate.
Statistical Analysis
Immunostaining data were analyzed by the two-sided Fisher's exact test using the InStat software program (GraphPad Software; San Diego, CA). The number of cases with abnormal staining pattern in one experimental group (e.g., normal) was compared with the number of cases with abnormal staining pattern in another experimental group (e.g., PBK). P value less than 0.05 was considered significant.
RNA Analysis
Immunohistochemistry with antibodies specific for AQP4 showed positive staining in the human cornea. Because AQP4 had not been previously described in the human cornea, we also analyzed corneas for the presence of AQP4 mRNA. In addition, it has been controversial whether AQP1 is present in epithelial cells (Hamann et al. 1998; Bildin et al. 2001; Thiagarajah and Verkman 2002; Macnamara et al. 2004) . Therefore, we examined the whole intact cornea, isolated epithelial cells, and cultured stromal fibroblasts for AQP1 mRNA by RT-PCR.
Tissues prepared for RNA analyses were normal whole corneas ( n ϭ 4), PBK/ABK whole corneas ( n ϭ 3), isolated epithelial cells ( n ϭ 4), cultured normal corneal fibroblasts ( n ϭ 4), and cultured PBK corneal fibroblasts ( n ϭ 1). RNA analysis was carried out as described previously Saghizadeh et al. 1998; Spirin et al. 1999 ). The whole corneas were frozen in liquid nitrogen and pulverized into powder. The epithelial cell layer was removed from the underlying Bowman's layer by gently scrapping with a sterile spatula and placed in PBS. The corneal fibroblasts were cultured as described above until nearly confluent and rinsed with PBS. Samples were placed in Trizol (Invitrogen), thawed on ice, and homogenized for 5 min. Chloroform was added (1/5 of the volume) and the phases were separated by centrifugation. The aqueous phase was collected, linear acrylamide was added to 10 g/ml, and the RNA precipitated by the addition of 0.5 vol of isopropanol. RNA was recovered by centrifugation at 4C and the pellet washed with 75% ethanol. The pellet was air-dried, resuspended in buffer, and processed over RNeasy columns (Qiagen; Valencia, CA). RNA was eluted with 50 l water and 10 g of linear acrylamide was added. The solution was adjusted with 2 M sodium acetate, pH 5.0, to 10% vol and precipitated with 2.5 vol ethanol. RNA was recovered by centrifugation, washed with 75% ethanol, and resuspended in 11 l of water. One l of the RNA was analyzed using an Agilent 2100 Bioanalyzer to verify both quantity and quality of the RNA.
Five hundred ng of RNA was reverse-transcribed in a 50l reaction volume containing 0.5 mM dNTPs, 2.5 M random decamer primers, 20 U RNase inhibitor, and 200 U Su-perScript II reverse transcriptase (Invitrogen). Reactions were carried out for 10 min at 25C, 1 hr at 42C, and 5 min at 95C, followed by cooling to 4C. After synthesis, the cDNA was diluted to equivalent input RNA levels with TE (10 ng input RNA/ l) and stored at Ϫ 20C. The cDNA samples were subjected to PCR using specific primers for AQP4 (Wang et al. 2003) : forward AQP4, 5 Ј -TGGCTTCTGATG-CTGATTTG-3 Ј , reverse AQP4, 5 Ј -TTGCAATGCTGAG-TCCAAAG-3 Ј , product size 237 bp. The reaction mixtures for AQP1 and AQP4 contained 1 l of the cDNA, 1.5 mM MgCl 2, , 0.2 mM dNTP, and 0.2 M primers. The AQP4 reaction was carried out for 35 cycles, 94C, 30 sec; 56C, 30 sec; 72C; 1 min. The primers for the AQP1 were forward, AQP1 5 Ј -GTCCAGGACAACGTGAAGGT and reverse, AQP1, 5 Ј -GAGGAGGTGATGCCTGAGAG, product size 218 bp. The AQP1 was 35 cycles, using 94C, 30 sec; 60C, 30 sec; 72C, 1 min. Primers for ␤ 2 -microglobulin ( ␤ 2 -MG) were forward 5 Ј -CTCGCGCTACTCTCTCTTTCTG and reverse 5 Ј -GCTTACATGTCTCGATCCCACTT, product size 334 bp. The ␤ 2 -MG reaction was 35 cycles, using 94C, 30 sec; 60C, 30 sec; 72C, 45 sec. PCR products were separated by electrophoresis on 1.5% agarose gels, stained, and visualized under UV light with ethidium bromide. The Webcutter program was used to identify restriction sites within the AQP1 and AQP4. PCR products were digested with Pvu II (New England Biolabs; Beverly, MA) and Stu I (Invitrogen) according to the manufacturer's protocols. Predicted fragment sizes for AQP4 after Pvu II were 198 bp and 39 bp and for StuI were 138 bp and 99 bp. Predicted fragment sizes for AQP1 after Pvu II were 122 bp and 96 bp. Routine RT-PCR controls without reverse transcriptase were negative. Figure 1 shows a slit-lamp photograph of a PBK cornea. The edges of the slit lamp beam are irregular (arrowheads), consistent with fluid accumulation. Note that the cornea has decreased transparency, which obscures the view of the iris and pupil.
Results

AQPs in Diseased Corneas
AQP1. Immunostaining detected AQP1 in the stromal cells of all corneas examined (Figures 2 and 3; Table 1). The endothelial cells of the normal corneas and keratoconus corneas had AQP1. Although the PBK corneas and Fuchs' dystrophy corneas had fewer endothelial cells, when present they also stained with AQP1. The epithelial cells did not stain with the AQP1 antibody ( Figure 2 ). RT-PCR with primers specific for AQP1 showed a single band of 218 bp, the expected size for AQP1 ( Figure 4A ). cDNAs from either whole normal corneas ( n ϭ 4), PBK/ABK corneas ( n ϭ 3), or isolated epithelial cells ( n ϭ 4) were analyzed for AQP1 mRNA ( Figure 4A ). After normalization to the ␤ 2 -MG, the AQP1 mRNA levels in normal corneas vs PBK/ABK corneas were found to be similar ( Figure  4A , Lanes 1 and 2). The epithelial cells were devoid of AQP1 transcript ( Figure 4A , Lane 3), suggesting that this layer did not contribute to the AQP1 mRNA levels found in the whole corneas. Corneal fibroblasts cultured from normal corneas ( n ϭ 4) or a PBK cornea ( n ϭ 1) maintained AQP1 mRNA expression in vitro ( Figure 4A , Lanes 4 and 5). The 218-bp band was subjected to Pvu II restriction enzyme and yielded two bands of 122 bp and 96 bp, which correspond to the expected sizes for digestion of AQP1 ( Figure 4B ).
AQP3. AQP3 was found mainly in the basal epithelial cells and some stromal cells of the normal corneas, Fuchs' dystrophy corneas, and keratoconus corneas ( Figure 2) . The PBK/ABK corneas had increased intensity of AQP3 staining with a distribution in both the basal and superficial epithelial cells. The stromal cells associated with subepithelial fibrosis in keratoconus corneas (8/10; p Ͻ 0.003), Fuchs' dystrophy corneas (9/10; p Ͻ 0.006), and PBK corneas (8/12; p Ͻ 0.01), showed increased AQP3 staining compared with normal corneas (2/13) ( Figure 2 ; Table 1 ). There was nonspecific staining of the endothelial cells with the AQP3 antibody ( Figure 3 ).
AQP4. In the normal corneas AQP4 was absent in epithelial cells and stromal cells ( Figure 2) but present in the endothelial cells (Figure 3 ). There was a significant increase of AQP4 that appeared in the stromal cells of the PBK/ABK corneas (7/8) compared with normal corneas (0/13; p Ͻ 0.0001) (Figures 2 and 3 ; Table 1). It has been controversial as to whether AQP4 was expressed in human corneas. Therefore, in addition to the IHC staining with the specific antibody, we also examined the AQP4 mRNA levels ( Figure 4C ). The mRNA for AQP4 was found in corneas with an expected size of 237 bp ( Figure 4C , Lane 1). After Pvu II and Stu I treatments, the fragments showed the expected sizes of 198 bp and 39 bp ( Figure 4C , Lane 2) or 138 bp and 99 bp ( Figure 4C, Lane 3) , respectively. This supports the presence of AQP4 within the human cornea. AQP5. AQP5 was found in epithelial cells of normal and diseased corneas ( Figure 2) and was prominent in the conjunctival cells (not shown). In addition, AQP5 was found in some cells of the anterior stroma of PBK/ ABK corneas (4/10) and keratoconus corneas (6/10) and in some posterior stromal cells adjacent to Descemet's membrane in Fuchs' dystrophy corneas (5/10) ( Figure 3 ). This stromal staining was not significant because occasional staining of stromal cells was also seen in normal corneas (5/10).
In this study we tested three different AQP5 antibodies but saw staining only with the goat polyclonal antibody (G-19:sc-9890) from Santa Cruz Biotechnology. However, the AQP5 staining pattern of the epithelial cells was unusual in that it was punctate rather than having a membrane association. To verify the AQP5 specificity, the antibody was combined with the AQP5 blocking peptide before exposure to the tissues. In these cases, the staining was eliminated from the epithelial cells and stromal cells, suggesting specificity. The endothelial cells had nonspecific staining ( Figures  2 and 3) .
For comparison to diseased corneas, we also examined corneas from patients that had undergone cataract surgery and had an intraocular lens in place. These PCS corneas had AQP patterns similar to those of normal corneas (data not shown).
The organ-cultured corneas were also examined ( Figures 2 and 3 ). AQP1 was found in the stromal cells and in the endothelial cells. AQP3 antibody stained the basal epithelial cells and some stromal cells. AQP4 antibody stained only the endothelial cells. AQP5 antibody stained the epithelial cells and the conjunctiva. After prolonged cultures, these corneas exhibited swelling. In general, however, the AQP staining patterns of the corneas that were maintained in organ culture were similar to those found in the normal corneas.
Discussion
PBK/ABK and Fuchs' dystrophy are two major corneal diseases that have endothelial cell dysfunction and chronic edema as major components of the pathological process. In these disorders fluid accumulates within epithelial cells (microcysts) and corneal thickness can increase 100-300 m, leading to loss of transparency and decreased vision. We present a comprehensive study of seven different AQPs comparing normal corneas to three different corneal diseases (PBK/ABK, Fuchs' dystrophy, and keratoconus), postcataract surgery corneas, and organ-cultured corneas. We find that PBK/ABK corneas have altered distribution in AQP1, AQP3, and AQP4. Fuchs' dystrophy corneas have AQP1 changes. The non-edematous cor-Figure 2 Aquaporins (AQPs) in epithelium and anterior stroma of normal and diseased corneas. Immunofluorescent staining with specific antibodies. (AQP1) Note staining of stromal cells in normal and diseased corneas. (AQP3) Note expression in some of the basal epithelial cells in normal, keratoconus and Fuchs' dystrophy corneas. In PBK/ABK corneas, the AQP3 epithelial staining is generally more uniform and brighter than in any other corneal group. The stromal cells in region of extracellular matrix disruption and fibrosis are AQP3-positive. (AQP4) Note increased staining in the stromal cells of PBK/ ABK corneas. (AQP5) Epithelial cells stain in a punctate-like pattern in normal and diseased corneas. Some stromal cells are AQP5-positive. Corneal sections treated with AQP5 blocking peptide were negative. In normal organ-cultured corneas, staining patterns of all studied AQPs are similar to intact normal corneas. NL, normal corneas; PBK, pseudophakic bullous keratopathy; Fuchs', Fuchs' dystrophy; KC, keratoconus corneas; Organ culture, normal corneas cultured for up to 14 days; Negative control, secondary antibodies only. Bar ϭ 60 m. neas (keratoconus and PCS corneas) are essentially normal in their AQP patterns.
AQPs in Diseased Corneas
AQP1. Our findings for AQP1 antibody staining in normal stromal cells and endothelial cells are in agreement with other studies (Hamann et al. 1998; Wen et al. 2001; Thiagarajah and Verkman 2002; Macnamara et al. 2004 ). The corneal epithelial cells did not have AQP1 immunostaining, and we provide evidence that isolated human epithelial cells lack the AQP1 mRNA. Our results differ from those of a study that reports AQP1 mRNA in bovine epithelial cells (Bildin et al. 2001) . This discrepancy may be accounted for by species differences (human vs bovine) or isolation procedures. In their study, the bovine epithelial layer was separated by exposure to a lysate buffer containing 5 M guanidine thiocyanate and 0.1 M EDTA. In contrast, we mechanically separated the epithelial cells from underlying stroma with a gentle scraping procedure. To the best of our knowledge, there are no reports of positive immunostaining with AQP1 antibodies in the corneal epithelial cells (Hamann et al. 1998; Wen et al. 2001; Thiagarajah and Verkman 2002; Macnamara et al. 2004) .
Our results also agree with a recent report showing that AQP1 was decreased in corneas with endothelial cell dysfunction (Macnamara et al. 2004) . In our study, AQP1 mRNA levels from the whole normal corneas were not different from PBK/ABK corneas. However, we recognize that if PBK/ABK or Fuchs' dystrophy corneas had a decline in the endothelial cell mRNA, it is unlikely that we would have picked it up because we were analyzing all layers of the cornea together rather than isolated endothelium.
It is recognized that corneal endothelial cells have a significant role in pumping fluid out of the cornea via the Na ϩ ,K ϩ -ATPase pump (Sasaki et al. 1986 McCartney et al. 1987a Guggenheim and Hodson 1994) . Our studies showed that endothelial cells of PBK/ABK corneas and Fuchs' dystrophy corneas had normal staining for the Na ϩ ,K ϩ -ATPase ␣-subunits (Ljubimov et al. 2002) and lower levels of AQP1. Our findings along with those of others (Thiagarajah and Verkman 2002; Verkman 2003; Macnamara et al. 2004) suggest that AQPs may be more important in corneal fluid dynamics than previously recognized.
A function of AQP1 in the cornea may be fluid elimination from the stroma across the endothelial cells because AQP1 null mice have delayed recovery of corneal transparency and increased thickness after treatment with hypotonic solutions (Thiagarajah and Verkman 2002; Verkman 2003) . This proposed function is supported by our findings and those of others (Macnamara et al. 2004) showing that AQP1 is decreased in the endothelial layer of Fuchs' dystrophy and PBK/ ABK corneas. We found an overall decrease in AQP1 antibody staining due to the fewer numbers of endothelial cells, but a number of sparse cells present still Note that PBK corneas have many AQP4-positive stromal cells compared with normal or other diseased corneas. (AQP5) Scattered cells of the posterior stroma are positive and staining is eliminated by treatment with AQP5 blocking peptide. Endothelial cells have nonspecific staining for AQP5. In normal organ-cultured corneas, staining patterns of all studied AQPs are again similar to those of intact normal corneas. NL, normal corneas; PBK, pseudophakic bullous keratopathy; Fuchs', Fuchs' dystrophy; KC, keratoconus corneas; Organ culture, normal corneas cultured for up to 14 days; Negative control, secondary antibodies only. Bar ϭ 60 m.
were positive. AQP1 is also decreased in a mouse model of corneal endothelial cell injury with subsequent corneal thickening (Macnamara et al. 2004) . One can speculate that, in the PBK/ABK corneas and Fuchs' dystrophy corneas, as AQP1 declines fluid accumulates within the stroma and subepithelial bullae. In PBK/ABK corneas and Fuchs' dystrophy patients, it is not unusual to find corneal thickness increased to 600-850 m (normal thickness is ‫055ف‬ m). Taken together, these studies suggest that upregulation of the endothelial cell AQP1 might lead to fluid elimination, decreased stromal swelling, and increased corneal transparency for these patients.
AQP3. AQP3 belongs to the aquaglyceroporin subset of the AQP family. Others have reported modest levels of AQP3 in corneal epithelium (Hamann et al. 1998) . We found AQP3 associated with the membranes of the basal epithelial cells in normal corneas, Fuchs' dystrophy corneas, keratoconus corneas, and organ-cultured corneas. This basal cell AQP3 localization is in agreement with that described for epidermal keratinocytes of mouse skin (Ma et al. 2002) and pulmonary epithelial cells (Funaki et al. 1998) . We are the first to report that PBK/ABK corneas have additional AQP3 immunostaining in the superficial epithelial cells. Functionally, AQP3 null mice have decreased "water holding capacity" compared with wild-type mice (Ma et al. 2002) . If this function holds for the cornea, then the appearance of AQP3 in the superficial epithelium may be associated with increased fluid accumulation. This might be related to the classic epithelial microcysts representing intracellular fluid found in PBK/ABK corneas (Grayson 1983 ). On the basis of both animal and human tissue studies, we hypothesize that inhibition or blocking of AQP3 might decrease the "water holding capacity" of cells and aid in decreasing the numbers of microcysts that form within PBK/ABK corneal epithelial cells. Surprisingly, we found increased AQP3 associated with stromal cells in areas of fibrosis in PBK/ABK corneas (8/12; pϽ0.01), Fuchs' dystrophy corneas (9/10; pϽ0.01), and keratoconus corneas (8/10; pϽ0.01) compared with normal corneas (2/13). We suspect that this increased focal staining of the AQP3 is associated with the process of scarring or tissue remodeling because it was found also in fibrotic regions of keratoconus corneas, a disease of thinning and focal scarring but not associated with chronic edema. Perhaps specific "wound healing" cells have a higher expression of AQP3 than normal. Further studies are needed to understand this finding.
AQP4. This is the first study to report AQP4 mRNA within normal human corneas. Our IHC studies localized the AQP4 to the endothelial cells in normal and diseased corneas. Our findings are different from those that report no AQP4 in corneal endothelial cells or cultured bovine endothelial cells (Hamann et al. 1998; Wen et al. 2001) . The discrepancies may be related to species, frozen vs paraffin sections, or the specific antibody used. Because human corneal AQP4 had not been described previously, we also analyzed the corneas for AQP4 mRNA. Using RT-PCR with specific primers for AQP4, we found the expected size product for AQP4 that cut properly with two different restriction enzymes (Pvu II and Stu I). Although significant amounts of AQP4 mRNA are found in brain, lower levels have also been found in the eye by Northern blotting and RNase protection assay (Jung et al. 1994) . The highest levels of AQP4 are found in the retina (Patil et al. 1997; Hamann et al. 1998 ), but it is present in lower amounts in ciliary body, iris, and lens (Patil et al. 1997 ). In addition, AQP4 mRNAs are also described in non-ocular tissues such as muscle, Meckel's cartilage, fetal tooth, and submandibular gland (Wang et al. 2003; Trujillo et al. 2004 ). In the normal human cornea, AQP1 and AQP5 are in great abundance (Patil et al. 1997) , with AQP4 being a minor component. Surprisingly, the IHC staining for AQP4 antibody was different in the PBK/ABK corneas compared with normal corneas or those affected by other diseases. There was a significant increase in the AQP4-positive stromal cells in PBK/ABK corneas (7/8) compared with normal corneas (0/13; pϽ0.0001). Usually AQP4 is associated with regulation of fluid movement between the vessels and brain parenchyma, and it is not clear what role AQP4 might play in PBK/ABK corneas, especially since the cornea is avascular. Based on AQP4 null mice studies, it has been suggested that AQP4 was associated with tissue swelling and that mice that lack AQP4 are protected from brain edema (Papadopoulos et al. 2002) . Absence of AQP4 also reduces intraocular pressure by lowering aqueous humor production in these mice (Zhang et al. 2002) . If this holds for the human cornea, then the increase of AQP4 in stromal cells might contribute in some way to the swelling found in PBK/ABK corneas, although the mechanism is still not clear. Alternatively, AQP4 might be associated with a specific cell type, such as macrophages (CD-14-positive cells), which are found in PBK/ABK corneas and not in keratoconus or normal corneas (Kenney et al. 2001) . It should also be considered that the altered AQP pattern may be a response to upregulation of growth factors (i.e., IGF-I or BMP-4) present in PBK/ABK corneas (Saghizadeh et al. 2001) , because studies showed that AQP gene expression can be altered in response to cytokines/growth factors (Borok et al. 1998; Smith et al. 1999; Fasshauer et al. 2003) . Using gene silencing techniques, alternative functions have been proposed for AQP4, such as a role in maintaining cell morphology, cell plasticity, and regulation of ischemia-related genes (Nicchia et al. 2003) . Further investigations of PBK/ABK corneas are necessary to clarify the role of AQP4 in cell behavior and tissue fluid dynamics.
AQP5. There was no significant difference in the staining pattern for AQP5 in epithelial cells of normal corneas and diseased corneas. Within the stroma, a small number of AQP5-positive cells were adjacent to either Bowman's layer or Descemet's membrane, and nonspecific staining of the endothelial cells was found. AQP5 has been described in rat, mouse, and human corneal epithelium (Raina et al. 1995; Hamann et al. 1998; Thiagarajah and Verkman 2002) .
AQP5 plays an interesting role in the cornea. It is found in epithelial cells, and although AQP5 null mice have increased corneal thickness, the baseline corneas remain clear (Thiagarajah and Verkman 2002) . However, after exposure of the epithelial surface to hypotonic saline (100 mOsm), the recovery rate of corneal swelling was significantly decreased, suggesting that AQP5 is important in fluid elimination via the epithelium (Thiagarajah and Verkman 2002) . It should be considered that epithelial cell dysfunction may play a role in corneal edema-related diseases because in PBK/ ABK corneas these cells have abnormal Na ϩ ,K ϩ -ATPase ␣-subunits (Ljubimov et al. 2002) and altered distribution of AQP3. Further studies should be conducted to clarify the role of epithelial cells in corneal fluid dynamics.
It was surprising to us that Fuchs' dystrophy corneas and PBK/ABK corneas had different AQP patterns because both diseases have many of the same clinical features. One explanation for this difference may be that Fuchs' dystrophy has a genetic component, a mutation in the ␣2-chain of type VIII collagen, which is present in Descemet's membrane, the substrate for the endothelial cells (Biswas et al. 2001) . In contrast, all PBK/ABK corneas have had previous surgery (cataract removal) with the loss of endothelial cells, usually suspected to be traumatic (excessive irrigation during phacoemulsification, corneal contact during intraocu-lar lens placement, postoperative contact with an anterior chamber intraocular lens) and may have an inflammatory component that Fuchs' dystrophy corneas lack. Although the common final pathway in both PBK/ABK corneas and Fuchs' dystrophy corneas is an abnormal accumulation of fluid, the underlying mechanisms leading to the disease process might be different.
Long-term corneal organ cultures have similar AQP patterns to those of the normal in situ corneas and may provide a viable model for future studies into AQP function and regulation. Even after 14 days in culture and various degrees of swelling, the organ-cultured corneas had AQP patterns similar to normal corneas. This organ culture model allows up to 1-month culture of intact whole human corneas (Foreman et al. 1996; Harper et al. 1998 ). Our recent data showed that normal expression patterns of basement membrane components and integrins were maintained during this extended incubation (Kabosova et al. 2003) . It can be suggested that the edema observed in PBK/ABK and Fuchs' dystrophy corneas has a different pathological mechanism of swelling than observed in organcultured corneas, where it was apparently due to osmosis-related lateral influx through the severed sclera. Corneal swelling in diseased corneas may involve alterations in Na ϩ ,K ϩ -ATPase and/or AQPs, some of which have been described here in detail. Understanding the functions of the corneal AQPs may allow the development of therapeutic interventions that would prevent pathological corneal swelling and preserve visual acuity in the PBK/ABK and Fuchs' dystrophy patients.
Literature Cited
